πŸ‡ΊπŸ‡Έ FDA
Patent

US 11992514

Ready-to-use bivalirudin compositions

granted A61KA61K38/10A61K38/58

Quick answer

US patent 11992514 (Ready-to-use bivalirudin compositions) held by MAIA PHARMACEUTICALS, INC. expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
MAIA PHARMACEUTICALS, INC.
Grant date
Tue May 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K38/10, A61K38/58, A61K47/02, A61K47/10